Rodos BioTarget Starts Their Crowdfunding Campaign

14-July, Hanover – German biotech company Rodos BioTarget has started their venture capital crowdfunding campaign on Seedmatch today at 12:00 local time. With an overall goal of €200k to be funded in a period of 60 days, they have already drawn 38 personal venture capital investors to support them with more than €50k in less than 5 hours after launch of the campaign. They are working on targeted drug delivery, to more effectively fight viral and bacterial diseases. The company has been founded by Marcus Furch, Michael Scolaro, Robert Gieseler and Jorg Ruppert in 2008.

Photo credit: Rodos BioTarget
Source: CrunchBase, Seedmatch, Rodos BioTarget
Editorial notice: On 16-July we were contacted by principal founder Robert Gieseler about a mistake in the data from CrunchBase about the founder’s names. This has now been corrected from Robert Crone to Robert Gieseler.

Christopher Isak

Christopher Isak

Managing Editor at TechAcute
Hi there and thanks for reading my article! I'm Chris. I write about tech news, management subjects. Reach out via Twitter or comments, if you like. I'd love to hear from you!
Christopher Isak

@ChristopherIsak

Journalist for Tech News + Innovation ✖ Hell-bent for truth and progress ✖ Founder of @TechAcuteCom ✖ Geek and Gamer ✖ Collaboration all the way ✖ INTJ
Headstart wants to better analyze candidates to fit them with the best jobs https://t.co/Lfp3uK3AiA - 46 mins ago
Christopher Isak

Christopher Isak

Hi there and thanks for reading my article! I'm Chris. I write about tech news, management subjects. Reach out via Twitter or comments, if you like. I'd love to hear from you!